Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
Prog Urol ; 25(7): 420-7, 2015 Jun.
Artigo em Francês | MEDLINE | ID: mdl-25891781

RESUMO

OBJECTIVE: To determine whether obesity is associated with adverse pathologic characteristics, positive surgical margins and the biochemical recurrence free survival (bRFS) after primary treatment with radical prostatectomy (RP). PATIENTS AND METHODS: Medical charts of patients managed with RP between 1999 and 2011 for localized prostate cancer (PCa) were retrospectively reviewed. Population study was split into two groups according to the body mass index (BMI): non obese (BMI< 30 kg/m(2)) and obese (BMI ≥ 30 kg/m(2)). Correlations between obesity and adverse pathological features or bRFS were assessed using univariable and multivariable analyses. RESULTS: Overall, 328 patients were included in the present study: 278 (84.8%) obese and 50 (15.2%) non obese. In multivariable analysis, obesity was associated with positive surgical margins (P=0.014), extracapsular extension (P=0.004) and pathologic Gleason score ≥ 7 (P=0.048). Obesity was not associated with seminal vesicle invasion (P=0.636) and lymph node metastasis (P=0.132). After a mean follow-up of 60.51 ± 28.82 months, no statistical difference in terms of bRFS was observed between the two groups (P=0.186). Furthermore, obesity was not an independent predictor of bFS in multivariable analysis. CONCLUSION: Obesity was associated with adverse pathologic characteristics and positive surgical margins but no statistical correlation was found with bRFS. LEVEL OF EVIDENCE: 5.


Assuntos
Obesidade/complicações , Prostatectomia , Neoplasias da Próstata/patologia , Neoplasias da Próstata/cirurgia , Idoso , Intervalo Livre de Doença , Humanos , Masculino , Pessoa de Meia-Idade , Recidiva Local de Neoplasia/etiologia , Prostatectomia/métodos , Estudos Retrospectivos , Resultado do Tratamento
2.
Prog Urol ; 24(10): 634-9, 2014 Sep.
Artigo em Francês | MEDLINE | ID: mdl-25214292

RESUMO

OBJECTIVE: To analyze results and morbidity after flexible ureterorenoscopy (fURS) in patients with a body mass index (BMI)>30 kg/m² and to compare with results obtained in a large cohort of non-obese patients. METHODS: We conducted a retrospective monocenter study including all fURS for urinary lithiasis performed in our institution between January 2004 and December 2010. During the study period, 497 procedures were performed. Twenty-three had to be excluded because of missing data on BMI. Thus, a total of 474 procedures were included in the final analysis, 93 for obese patients (OP) and 381 for non-obese patients (NOP). Characteristics of the patients, stones and procedures were analyzed. Success was defined as clear imaging (completely stone-free) on renal tomography and ultrasonography. RESULTS: Mean BMI was 33.5 ± 0.3 in OP vs 23.9 ± 0.1 kg/m² in NOP (P<0.0001). Mean stone size, location, and composition were not significantly different between groups. Technical aspects (operative time, ureteral dilatation, access sheath, monobloc extraction) were also similar in OP and NOP. The immediate (63.5% for OP vs 66.1% in NOP, P=0.62) and follow-up (65.1% for OP vs 71% in NOP, P=0.26) stone-free rate were not significantly different between the groups. For stone size<1cm, SFR raised to 77% in OP vs 83% in NOP (P=0.28). The rate of minor complications Clavien II was similar in OP (7.5%) and NOP (12%). No major complication (Clavien III or IV) was observed. CONCLUSION: fURS is a safe and efficient option for the management of urinary lithiasis in obese patients.


Assuntos
Obesidade/complicações , Ureteroscopia/efeitos adversos , Urolitíase/complicações , Urolitíase/cirurgia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Complicações Pós-Operatórias/epidemiologia , Complicações Pós-Operatórias/etiologia , Estudos Retrospectivos
3.
Prog Urol ; 24(9): 535-9, 2014 Jul.
Artigo em Francês | MEDLINE | ID: mdl-24975786

RESUMO

INTRODUCTION AND OBJECTIVES: The aim of this study was to analyze the weather influence on the onset of renal colic (RC), acute urinary retention (AUR) and testicular torsion (TT). MATERIALS AND METHODS: We correlated the daily number of RC, AUR and TT cases admitted to our urology department and weather conditions between 2005 and 2009 on day-to-day basis. Eight hundred and seventy-six RC, 453 AUR and 50 TT were analyzed. Information on temperature, atmospheric pressure, relative humidity, vapor pressure, wind force, evapotranspiration and sunshine level were collected from the national meteorological office (Meteo-France) in Besançon, France. We performed a univariate and a multivariate Stepwise method in linear regression using Akaike Information Criterion. RESULTS: We reported a statistically significant increased risk of renal colic at higher vapor pressure. Likewise, temperature seemed to be a risk factor for occurrence of renal colics. We determined an increased daily rate when maximal daily temperature rises above 20 Celsius degrees (P = 0.05). Furthermore, we observed a positive link between mean (P = 0.05) and minimal (P = 0.08) daily temperature and urolithiasis. Contrarywise AUR was more frequent when the mean temperature falls below zero Celsius degree. We also demonstrated a non-significant influence of temperature on TT, with 3 fold higher events during cold period. Much more mystic, we noted a higher AUR rate on new moon days, and fewer renal colic on full moon. CONCLUSIONS: Further investigations are necessary to understand the mechanisms underlying the relationship between urologic diseases and climate. But our findings could help us justify healthy living messages.


Assuntos
Cólica Renal/epidemiologia , Doenças Testiculares/epidemiologia , Anormalidade Torcional/epidemiologia , Retenção Urinária/epidemiologia , Tempo (Meteorologia) , Adulto , Idoso , Emergências , Feminino , França , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos
4.
Prog Urol ; 24(7): 433-40, 2014 Jun.
Artigo em Francês | MEDLINE | ID: mdl-24861683

RESUMO

OBJECTIVES: To analyze the impact of the existence of Gleason grade 5 on the adverse pathology and biochemical recurrence-free survival of patients. PATIENTS: Three hundred and seventy-two prostatectomies were performed between 1999 and 2011 in our institution for localised prostate adenocarcinoma. We examined the existence of grade 5 of the specimen to determine the reliability of prostate biopsies in the diagnosis of grade 5 and the association of grade 5 with other histoprognostic factors. Biochemical recurrence-free survival was analyzed according to the presence of grade 5 in the final specimen. RESULTS: In total, all histological data and biochemical recurrence-free survival were available for 321 patients who were included in the study. Sixty-eight had Gleason grade 5 (majority or third minority pattern) on the specimen while 253 had not. Grade 5, rarely diagnosed on biopsy (sensitivity=26.47 %) was correlated independently with the extracapsular extension (OR=2.1; CI 95 [1.1-3.9]), the seminal vesicle invasion (OR=3.8; CI 95 [1.7-8.7]) and positive surgical margins (OR=2.0; CI 95 [1.1-3.6]). Overall survival was similar in both groups but the biochemical recurrence-free survival was statistically lower in the presence of grade 5 (HR=3.7; CI 95 [1.8-7.6]). Biochemical recurrence-free survival was not different than grade 5 is predominant or third minority pattern (HR=1.01; CI 95 [0.3-2.8]). On multivariate analysis, grade 5 was an independent risk factor for biochemical recurrence (P=0.005) as well as seminal vesicle invasion (P=0.047). CONCLUSION: The existence of grade 5 in the surgical specimen whatever the percentage was a poor prognostic factor associated with increased tumor aggressiveness and reduced biochemical recurrence-free survival. LEVEL OF EVIDENCE: 5.


Assuntos
Recidiva Local de Neoplasia/mortalidade , Antígeno Prostático Específico/sangue , Prostatectomia , Neoplasias da Próstata/mortalidade , Neoplasias da Próstata/patologia , Adenocarcinoma/sangue , Adenocarcinoma/mortalidade , Adenocarcinoma/patologia , Adenocarcinoma/cirurgia , Humanos , Masculino , Pessoa de Meia-Idade , Análise Multivariada , Gradação de Tumores , Invasividade Neoplásica , Prognóstico , Neoplasias da Próstata/sangue , Neoplasias da Próstata/cirurgia , Glândulas Seminais/patologia
5.
Pesquisa Veterinaria Brasileira ; 31(6): p.538-42, 2011.
Artigo em Inglês | Sec. Est. Saúde SP, SESSP-IBPROD, Sec. Est. Saúde SP | ID: but-ib12407
6.
Placenta ; 29(1): p.106-, 2008.
Artigo em Inglês | Sec. Est. Saúde SP, SESSP-IBPROD, Sec. Est. Saúde SP | ID: but-ib9605
7.
J Am Coll Cardiol ; 15(3): 633-9, 1990 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-2154512

RESUMO

The mechanisms responsible for intermittent bundle branch block are still under debate. The role of the time-dependent behavior of the slow calcium channel has recently been emphasized. To test this hypothesis and ascertain the possible involvement of the fast sodium channel, the effects of the slow calcium channel blocker verapamil and the fast sodium channel blocker procainamide were compared in 10 patients with intermittent bundle branch block. All 10 patients showed bundle branch block during spontaneous sinus rhythm. Maneuvers to slow cardiac rate (that is, carotid sinus massage, Valsalva maneuver) were performed to identify normal conduction as well as phase 4 bundle branch block. Thus, the ranges of diastolic intervals (RR) resulting in phase 3 (tachycardia-dependent) bundle branch block, phase 4 (bradycardia-dependent) bundle branch block and normal conduction were measured in two control studies performed before intravenous administration of verapamil (control 1) and procainamide (control 2) and at the peak effect of both drugs. In the control studies, all 10 patients showed phase 3 bundle branch block, whereas phase 4 bundle branch block occurred in only 4 patients. The ranges of phase 3 bundle branch block, phase 4 bundle branch block and normal conduction were very similar in control studies 1 and 2. The phase 3 bundle branch block range was slightly shortened by verapamil (983 +/- 83.5 ms in control 1; 930 +/- 69.4 ms at the peak effect of verapamil), whereas phase 4 bundle branch block remained unchanged. In contrast, conduction was systematically worsened by procainamide.(ABSTRACT TRUNCATED AT 250 WORDS)


Assuntos
Bloqueio de Ramo/fisiopatologia , Procainamida/farmacologia , Canais de Sódio/efeitos dos fármacos , Verapamil/farmacologia , Adulto , Idoso , Bloqueio de Ramo/tratamento farmacológico , Eletrocardiografia , Feminino , Sistema de Condução Cardíaco/efeitos dos fármacos , Humanos , Masculino , Pessoa de Meia-Idade
8.
Arch. Inst. Cardiol. Méx ; 57(4): 325-30, jul.-ago. 1987. tab
Artigo em Espanhol | LILACS | ID: lil-61523

RESUMO

En 81 pacientes con miocarditis crónica chagásica (MCC) y arritmias ventriculares (AV) pertenecientes a 4 centros cardiológicos se evaluó comparativamente la eficacia y seguridad de flecainida (F) y amiodarona (A) utilizando un protocolo abierto, randomizado y paralelo. Fueron incluídos pacientes con un número de extrasístoles ventriculares (EV) no inferior a 1200/24 hs y/o formas repetitivas. Los pacientes fueron tratados durante 60 días con una de las drogas (F: 200 a 400 mg/día; A: 800 a 400 mg/día; dosis ajustada según respuesta) y evaluados clínicamente con exámenes de laboratorio, ECG en reposo y ECG ambulatorios continuos de 24 hs (H) días - 7; - 1; 8/9; 15/16; y 59/60). Los porcentajes de reducción de EV obtenidos a los 9, 16 y 60 días con F fueron 73.1%; 82.9% y 92.4% y con A77.6%; 90.1% y 90.7%. Después de 60 días de tratamiento, la Fredujo las duplas en 92.5% y los episodios de taquicardia ventricular en 96.5% y la A, 95.2% y 92.6%, respectivamente. El tratamiento debió ser interrumpido en 6 pacientes; 3 con F (2 por bradicardia sinusal extrema y 1 por TV iterativa), y 3 con A (1 por TV sostenida y 2 por fotodermatosis severa). Aunque existieron algunas diferencias llamativas en los resultados de los distintos centros, El análisis estadísticos en conjunto sugiere una similar eficacia de F y A en el tratamiento de las AV de la MCC


Assuntos
Adolescente , Adulto , Pessoa de Meia-Idade , Humanos , Masculino , Feminino , Amiodarona/uso terapêutico , Arritmias Cardíacas/tratamento farmacológico , Cardiomiopatia Chagásica/tratamento farmacológico , Flecainida/uso terapêutico , Ensaios Clínicos como Assunto , Eletrocardiografia , Frequência Cardíaca
9.
Arch Inst Cardiol Mex ; 57(4): 325-30, 1987.
Artigo em Espanhol | MEDLINE | ID: mdl-2445316

RESUMO

Eighty one patients with ventricular arrhythmias associated with chronic Chagas disease participated in this multi-clinic study. Treatment with Amiodarone and Flecainide were compared using an open, parallel, randomized experimental design. Inclusion criteria required the selected patients to have 1,200 premature ventricular contractions per 24 hours and/or repetitive ventricular arrhythmias. Patients received 60 days of treatment with either Flecainide at 200 to 400 mg per day or Amiodarone 800 to 400 mg per day. This dosage was adjusted to the therapeutic response. Clinical and laboratory evaluations, electrocardiogram and 24 hour Holters were performed at study days: -7, -1, 8/9, 15/16 and 59/60. The percentage reduction of premature ventricular contractions at days 9, 16 and 60 were: 73.1%, 82.9% and 92.4% with Flecainide and 77.6%, 90.1% and 90.7% with Amiodarone. At the end of the study, Flecainide had induced a 92.5% reduction in couplets and 96.5% reduction in ventricular tachycardia. For the same parameters the percentages following Amiodarone were 95.2% and 92.6% respectively. Treatment was discontinued in three patients in the Flecainide group (two because of prolonged sinus node bradycardia and one because of sustained ventricular tachycardia). In the Amiodarone group, treatment was discontinued also in three patients (one because of sustained ventricular tachycardia and two because of severe photosensitive dermatosis). Although there were some differences in the results form center to center, the conclusions from the overall data indicate a similar, therapeutic effect with both drugs.


Assuntos
Amiodarona/uso terapêutico , Arritmias Cardíacas/tratamento farmacológico , Cardiomiopatia Chagásica/complicações , Flecainida/uso terapêutico , Adolescente , Adulto , Idoso , Arritmias Cardíacas/complicações , Complexos Cardíacos Prematuros/complicações , Complexos Cardíacos Prematuros/tratamento farmacológico , Cardiomiopatia Chagásica/fisiopatologia , Doença Crônica , Ensaios Clínicos como Assunto , Avaliação de Medicamentos , Eletrocardiografia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Distribuição Aleatória , Taquicardia/complicações , Taquicardia/tratamento farmacológico
10.
J Am Coll Cardiol ; 9(6): 1269-78, 1987 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-3584719

RESUMO

It was recently shown that supernormal conduction in the diseased His-Purkinje system is more common than previously thought, and is always associated with prolongation of refractoriness. To assess whether supernormal conduction could also occur in the accessory pathway of patients with ventricular pre-excitation, 21 patients with manifestly prolonged refractoriness in the accessory pathway were studied. Under these conditions, programmed atrial stimulation revealed a phase of supernormal conduction in 16 (76%) of the 21. Therefore, what was believed to be a nonexistent or exceptional physiologic event was shown to be a rather common finding, at least under certain circumstances. Supernormal conduction occurred in all 7 patients with an anterograde refractory period of 480 to 980 ms, and in 5 of 10 patients with a refractory period greater than 1.0 second or with no anterograde conduction. Supernormal conduction could not be demonstrated in four patients with a refractory period less than or equal to 440 ms, but appeared in all four patients after the refractory period was prolonged by a rapid rate of stimulation or administration of ajmaline. The electrophysiologic changes underlying the occurrence of supernormal conduction in the accessory pathway are similar to those previously reported for the bundle branch system. The demonstration of supernormal conduction in the accessory pathway may uncover the presence of concealed ventricular pre-excitation. Supernormal conduction over the accessory pathway may facilitate a rapid ventricular response during atrial fibrillation, even if the refractory period is prolonged.


Assuntos
Sistema de Condução Cardíaco/fisiopatologia , Síndromes de Pré-Excitação/fisiopatologia , Ventrículos do Coração , Humanos , Vias Neurais/fisiopatologia , Período Refratário Eletrofisiológico , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...